Ainslie Hildebrand, MD, MSc; Christine Ribic, MD, MSc; Deborah Zimmerman, MD, MSc
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-1504.
Corresponding Author: Deborah Zimmerman, MD, MSc, University of Ottawa, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada; e-mail, email@example.com.
Current Author Addresses: Dr. Hildebrand: University of Alberta, 11-112R Clinical Sciences Building, 152 University Campus, Edmonton, Alberta T6G 2G3, Canada.
Dr. Ribic: St. Joseph's Hamilton Healthcare, 50 Charlton Avenue East, Marian Wing M311, Hamilton, Ontario L8N 4A6, Canada.
Dr. Zimmerman: Ottawa Hospital, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada.
Hildebrand A, Ribic C, Zimmerman D. Balancing the Benefits and Harms of Oral Anticoagulation in Chronic Kidney Disease: What Does Available Evidence Tell Us?. Ann Intern Med. 2019;171:214–215. [Epub ahead of print 16 July 2019]. doi: https://doi.org/10.7326/M19-1504
Download citation file:
Published: Ann Intern Med. 2019;171(3):214-215.
Published at www.annals.org on 16 July 2019
Chronic Kidney Disease, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use